Balchem Corp (NASDAQ: BCPC) is unchanged in post-market trading on Tuesday, with the specialty chemicals stock hovering just below its regular session close.
Why BCPC Is Flat Today
Balchem shares last traded at $165.76, down a marginal $0.02 from today's 4:00 PM ET close of $165.78. The session change amounts to roughly -0.01%.
Trading volume in the post-market session came in at about 65,800 shares, well below the stock's average daily volume of roughly 159,000 shares based on short interest data. The low volume suggests limited after-hours catalyst or urgency among buyers or sellers.
No fresh corporate announcements or SEC filings are driving the session move. The most recent news items include an upcoming presentation at the 9th Annual Wells Fargo Consumer Conference scheduled for September 23, 2026, and a second-quarter 2026 earnings conference call set for July 31, 2026.
What to Know About Balchem
Balchem Corporation develops and distributes specialty performance ingredients across several end markets, including nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial applications. The company operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Key product lines include encapsulated and emulsified powders for the food and beverage industry, specialty vitamin K2, human-grade choline nutrients, and mineral amino acid chelated products.
Looking Ahead
Balchem's last reported earnings were first-quarter 2026 results released on April 30, 2026. The company delivered Q1 results and has since confirmed plans to report second-quarter 2026 financials on July 31, 2026. Investors will be watching for any updates on demand trends across its human nutrition and animal health segments when that call takes place.
For now, the stock is holding steady in after-hours trading with no news-driven catalyst driving notable movement either direction.